RecruitingNCT05703386

Imaging the Pathogenesis of Cerebral Small Vessel Disease


Sponsor

Johns Hopkins University

Enrollment

50 participants

Start Date

Nov 8, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use serial MRI scanning to gain insights into the pathogenesis of CSVD.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using advanced brain imaging techniques to better understand a condition called cerebral small vessel disease — where small blood vessels in the brain become damaged over time, increasing the risk of stroke and memory problems. The goal is to identify what causes the disease to progress. **You may be eligible if...** - You have had a stroke or show signs of stroke on brain imaging - You have at least one cardiovascular risk factor (high blood pressure, high cholesterol, or diabetes) - Brain MRI shows evidence of small vessel disease **You may NOT be eligible if...** - You are unable to complete three research MRI visits over about 15 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Kennedy Krieger Institute

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05703386


Related Trials